ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Los Angeles, CA, USA:

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

(ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast...

Enrolling
Breast Cancer
Procedure: Breast Surgery
Drug: Pembrolizumab

Phase 2

The University of Texas System (UT)
The University of Texas System (UT)

Los Angeles, California, United States and 3 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Active, not recruiting
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

Los Angeles, California, United States and 4 other locations

This trial is a Phase 2 neoadjuvant study evaluating ARV-471 or anastrozole in post-menopausal women with ER+/HER2- localized breast cancer...

Active, not recruiting
Breast Cancer
Procedure: Surgical resection of breast tumor
Drug: ARV-471

Phase 2

Arvinas
Arvinas

Los Angeles, California, United States and 48 other locations

to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast...

Enrolling
Locally Advanced Breast Cancer
Metastatic Breast Cancer
Drug: U3-1402

Phase 2

SCRI Development Innovations

Duarte, California, United States and 10 other locations

This trial will evaluate the use of immunotherapy and PARP inhibition in a population with incurable advanced breast cancer associa ...

Enrolling
Breast Cancer
Drug: Olaparib
Drug: Pembrolizumab

Phase 2

Monica Mita

Los Angeles, California, United States

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...

Active, not recruiting
Breast Cancer
Drug: ARV-471 in combination with Everolimus

Phase 1

Arvinas
Arvinas

Santa Monica, California, United States and 8 other locations

in combination with either of two chemotherapy regimens (weekly paclitaxel or capecitabine) in unresectable/metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Paclitaxel
Drug: Capecitabine

Phase 1, Phase 2

Providence Health & Services
Providence Health & Services

Los Angeles, California, United States and 1 other location

of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, stage II-III, Estrogen Receptor positive, HER-2 negative breast...

Enrolling
Breast Cancer
Drug: Adjuvant Therapy
Drug: Palbociclib

Phase 2

Criterium

Los Angeles, California, United States and 14 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Los Angeles, California, United States and 226 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Los Angeles, California, United States and 62 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems